1. Home
  2. MLYS vs AESI Comparison

MLYS vs AESI Comparison

Compare MLYS & AESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$15.41

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Logo Atlas Energy Solutions Inc.

AESI

Atlas Energy Solutions Inc.

N/A

Current Price

$5.41

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MLYS
AESI
Founded
2019
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
MLYS
AESI
Price
$15.41
$5.41
Analyst Decision
Strong Buy
Buy
Analyst Count
11
13
Target Price
★ $45.22
$17.31
AVG Volume (30 Days)
1.8M
★ 4.1M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.43
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,095,310,000.00
Revenue This Year
N/A
$1.66
Revenue Next Year
N/A
$17.63
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.73
52 Week Low
$15.33
$6.63
52 Week High
$47.65
$20.13

Technical Indicators

Market Signals
Indicator
MLYS
AESI
Relative Strength Index (RSI) 28.91 18.79
Support Level N/A N/A
Resistance Level $31.19 $14.39
Average True Range (ATR) 1.42 0.77
MACD -0.40 -0.33
Stochastic Oscillator 6.21 7.74

Price Performance

Historical Comparison
MLYS
AESI

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About AESI Atlas Energy Solutions Inc.

Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.

Share on Social Networks: